ILMN - Illumina Inc Stock Price, Fair Value and News

122.27USD+1.22 (+1.01%)Market Closed

Market Summary

USD122.27+1.22

Market Closed

1.01%

ILMN Stock Price

View Fullscreen

ILMN RSI Chart

ILMN Valuation

Market Cap

19.4B

Price/Earnings (Trailing)

-16.74

Price/Sales (Trailing)

4.31

EV/EBITDA

-22.83

Price/Free Cashflow

68.65

ILMN Price/Sales (Trailing)

ILMN Profitability

Operating Margin

60.93%

EBT Margin

-24.79%

Return on Equity

-20.2%

Return on Assets

-11.48%

Free Cashflow Yield

1.46%

ILMN Fundamentals

ILMN Revenue

Revenue (TTM)

4.5B

Rev. Growth (Yr)

3.55%

Rev. Growth (Qtr)

0.27%

ILMN Earnings

Earnings (TTM)

-1.2B

Earnings Growth (Yr)

-26.26%

Earnings Growth (Qtr)

76.72%

Breaking Down ILMN Revenue

Last 7 days

4.1%

Last 30 days

-11.8%

Last 90 days

-13.1%

Trailing 12 Months

-40.2%

How does ILMN drawdown profile look like?

ILMN Financial Health

Current Ratio

1.66

ILMN Investor Care

Shares Dilution (1Y)

0.57%

Diluted EPS (TTM)

-7.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.4B	4.5B	4.5B	4.5B
2022	4.7B	4.7B	4.7B	4.6B
2021	3.5B	4.0B	4.3B	4.5B
2020	3.6B	3.4B	3.2B	3.2B
2019	3.4B	3.4B	3.5B	3.5B
2018	2.9B	3.1B	3.2B	3.3B
2017	2.4B	2.5B	2.6B	2.8B
2016	2.3B	2.3B	2.4B	2.4B
2015	2.0B	2.1B	2.1B	2.2B
2014	1.5B	1.6B	1.7B	1.9B
2013	1.2B	1.3B	1.3B	1.4B
2012	1.0B	1.0B	1.1B	1.1B
2011	993.1M	1.1B	1.1B	1.1B
2010	692.7M	743.1M	822.0M	902.7M
2009	0	604.3M	635.3M	666.3M
2008	0	0	0	573.2M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Illumina Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 05, 2024	rollins carissa	sold (taxes)	-15,585	127	-122	svp, chief information officer
Mar 28, 2024	ullem scott b.	acquired	22,442	137	163	-
Mar 05, 2024	thaysen jacob	acquired	-	-	29,702	chief executive officer
Mar 05, 2024	pegels kevin carl	acquired	-	-	5,569	chief of global operations
Mar 05, 2024	goswami joydeep	acquired	-	-	5,569	svp, chief financial officer
Mar 05, 2024	dadswell charles	acquired	-	-	6,683	svp, general counsel
Mar 05, 2024	rollins carissa	acquired	-	-	5,569	svp, chief information officer
Mar 05, 2024	leckman patricia	acquired	-	-	7,054	svp, chief people officer
Mar 05, 2024	reeves kathryne gambrell	acquired	-	-	5,569	svp, chief marketing officer
Mar 05, 2024	barnard steven	acquired	-	-	5,792	svp, chief technology officer

Which funds bought or sold ILMN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Chicago Partners Investment Group LLC	sold off	-100	-263,830	-	-%
Apr 25, 2024	Bogart Wealth, LLC	unchanged	-	-2.00	137	-%
Apr 25, 2024	WCM INVESTMENT MANAGEMENT, LLC	added	2,232	443,179,000	463,760,000	1.10%
Apr 25, 2024	Kinneret Advisory, LLC	reduced	-0.31	-34,711	2,024,510	0.20%
Apr 25, 2024	FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND	added	8.83	243,000	3,555,000	0.04%
Apr 25, 2024	Allworth Financial LP	added	212	72,847	107,797	-%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	added	15.92	1,620,480	12,936,100	0.04%
Apr 25, 2024	Verdence Capital Advisors LLC	new	-	411,411	411,411	0.04%
Apr 25, 2024	Center for Financial Planning, Inc.	new	-	412	412	-%
Apr 25, 2024	NATIXIS ADVISORS, L.P.	added	23.43	9,511,000	53,265,000	0.12%

Are Funds Buying or Selling ILMN?

Are funds buying ILMN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ILMN

No. of Funds

Unveiling Illumina Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.45%	18,177,520	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	13,302,678	SC 13G/A
Dec 05, 2023	baillie gifford & co	3.36%	5,332,416	SC 13G/A
Nov 20, 2023	baillie gifford & co	5.44%	8,608,269	SC 13G/A
Oct 10, 2023	vanguard group inc	11.35%	17,966,765	SC 13G/A
Feb 14, 2023	edgewood management llc	4.1%	6,478,370	SC 13G/A
Feb 09, 2023	vanguard group inc	8.28%	13,022,627	SC 13G/A
Jan 31, 2023	blackrock inc.	7.7%	12,051,653	SC 13G/A
Jan 20, 2023	baillie gifford & co	10.64%	16,743,103	SC 13G/A
Feb 14, 2022	edgewood management llc	5.6%	8,742,202	SC 13G

Recent SEC filings of Illumina Inc

View All Filings

Date Filed	Form Type	Document
Apr 24, 2024	3	Insider Trading
Apr 24, 2024	3	Insider Trading
Apr 12, 2024	8-K	Current Report
Apr 10, 2024	4	Insider Trading
Apr 09, 2024	8-K	Current Report
Apr 04, 2024	ARS	ARS
Apr 04, 2024	DEF 14A	DEF 14A
Apr 04, 2024	DEFA14A	DEFA14A
Apr 02, 2024	4	Insider Trading
Mar 12, 2024	3	Insider Trading

Peers (Alternatives to Illumina Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	182.5B	23.7B	-0.93%	6.50%	41.46	7.69	-8.94%	-35.72%
IDXX	41.5B	3.7B	-7.44%	3.05%	49.1	11.33	8.72%	24.44%
A	40.3B	6.7B	-6.59%	3.31%	32.64	5.99	-2.81%	-6.58%
DGX	14.9B	9.3B	2.40%	-4.82%	17.61	1.6	-3.29%	6.68%
MEDP	12.3B	2.0B	-1.91%	100.24%	39.22	6.24	25.57%	21.62%
CRL	11.8B	4.1B	-15.01%	24.62%	24.77	2.85	3.86%	-2.39%
NTRA	11.1B	1.1B	1.32%	82.46%	-25.45	10.22	31.99%	20.63%
EXAS	10.7B	2.5B	-11.98%	-7.20%	-52.35	4.28	19.93%	67.26%
MID-CAP
NEOG	2.6B	929.2M	-21.41%	-29.07%	1.7K	2.83	28.93%	111.61%
GH	2.1B	563.9M	-3.40%	-19.97%	-4.4	3.74	25.45%	26.76%
SMALL-CAP
CDNA	390.9M	280.3M	-28.23%	-2.96%	-2.05	1.39	-12.89%	-148.37%
ACRS	84.4M	31.2M	-5.56%	-86.21%	-0.95	2.7	5.03%	-1.81%
APDN	74.4M	9.0M	918.60%	338.04%	-10.29	8.27	-53.31%	2.21%
AWH	41.1M	9.2M	-2.92%	-32.04%	-2.46	4.49	11.85%	44.12%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Illumina Inc News

Latest updates

Illumina Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	0.3%	1,122	1,119	1,176	1,087	1,084	1,115	1,162	1,223	1,199	1,108	1,126	1,093	953	794	633	859	953	907	838	846	867
Cost Of Revenue	3.1%	449	435	444	432	411	398	395	408	382	338	324	329	323	268	205	240	290	259	265	262	278
Gross Profit	-1.5%	674	684	732	655	673	717	767	815	818	770	802	764	630	526	428	619	662	648	573	584	590
Operating Expenses	-41.8%	837	1,438	820	719	800	4,374	1,346	631	776	1,315	615	571	497	364	332	430	394	340	368	380	393
S&GA Expenses	59.4%	483	303	450	378	433	146	410	308	426	879	413	374	298	192	177	274	233	189	202	211	217
R&D Expenses	8.1%	341	315	358	341	346	325	327	323	350	436	202	197	199	172	155	156	161	151	166	169	176
EBITDA Margin	2.4%	-0.18*	-0.18*	-0.83*	-0.97*	-0.89*	-0.82*	0.05*	0.23*	0.25*	0.31*	0.28*	0.31*	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.6%	19.00	19.00	19.00	20.00	9.00	6.00	6.00	6.00	13.00	14.00	16.00	19.00	16.00	11.00	11.00	11.00	11.00	11.00	15.00	15.00	20.00
Income Taxes	128.6%	8.00	-28.00	145	-81.00	-28.50	144	-102	54.00	-25.50	103	22.00	22.00	42.00	36.00	118	5.00	30.00	36.00	53.00	9.00	12.00
Earnings Before Taxes	78.6%	-167	-782	-89.00	-78.00	-167	-3,672	-637	140	87.00	420	207	169	299	215	165	178	269	270	346	233	209
EBT Margin	0.9%	-0.25*	-0.25*	-0.90*	-1.02*	-0.95*	-0.87*	0.00*	0.18*	0.20*	0.26*	0.22*	0.24*	-	-	-	-	-	-	-	-	-
Net Income	76.7%	-175	-754	-234	3.00	-139	-3,816	-535	86.00	113	317	185	147	257	179	47.00	173	239	234	296	233	210
Net Income Margin	-2.4%	-0.26*	-0.25*	-0.94*	-1.01*	-0.96*	-0.88*	0.00*	0.15*	0.17*	0.21*	0.19*	0.18*	-	-	-	-	-	-	-	-	-
Free Cashflow	84.0%	173	94.00	58.00	-42.00	59.00	-118	54.00	111	212	-324	209	240	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.1%	10,111	10,122	11,774	11,811	12,252	11,256	15,448	15,274	15,217	15,063	8,675	8,755	7,585	7,404	7,248	7,261	7,316	7,089	6,973	7,390	6,959
Current Assets	4.1%	2,609	2,506	3,223	3,172	3,561	2,487	2,891	2,755	2,713	2,451	5,310	5,642	4,483	4,329	4,194	4,324	4,451	4,222	4,156	4,545	4,490
Cash Equivalents	13.1%	1,048	927	1,553	1,494	2,011	1,000	1,289	1,351	1,232	1,080	4,196	4,433	1,810	1,761	1,770	1,991	2,042	1,815	1,943	2,270	1,144
Inventory	-4.6%	587	615	617	586	568	559	518	465	431	401	380	364	372	415	435	384	359	417	420	412	386
Net PPE	-3.2%	1,007	1,040	1,069	1,082	1,091	1,068	1,055	1,034	1,024	1,009	915	915	922	910	890	890	889	875	854	852	1,075
Goodwill	0.7%	2,545	2,527	3,239	3,239	3,239	3,238	7,158	7,113	7,113	7,098	966	897	897	897	894	824	897	824	824	831	831
Current Liabilities	5.9%	1,570	1,482	2,303	2,230	2,773	2,669	2,881	1,490	1,093	914	874	1,268	1,244	1,115	1,115	1,054	665	619	612	1,241	1,804
Long Term Debt	-	-	-	-	-	-	-	-	746	702	694	687	680	673	666	659	652	1,141	1,131	1,120	1,112	890
LT Debt, Current	-	-	-	750	749	748	747	746	499	-	-	-	488	511	507	503	499	-	-	-	631	838
LT Debt, Non Current	-	-	-	-	-	-	-	-	746	702	694	687	680	673	666	659	652	1,141	1,131	1,120	1,112	890
Shareholder's Equity	-2.6%	5,745	5,898	6,555	6,693	6,599	6,731	10,444	10,895	10,740	10,593	5,180	4,922	4,694	4,700	4,563	4,635	4,613	4,439	4,332	4,070	3,845
Retained Earnings	-112.1%	-19.00	157	911	1,145	1,142	1,281	5,097	5,632	5,485	5,372	5,055	4,870	4,723	4,466	4,287	4,240	4,067	3,828	3,594	3,298	3,065
Additional Paid-In Capital	0.7%	9,555	9,487	9,397	9,311	9,207	9,129	9,033	8,957	8,938	8,849	3,993	3,914	3,815	3,737	3,649	3,631	3,560	3,510	3,436	3,385	126
Accumulated Depreciation	-	1,138	-	-	-	962	-	-	-	796	-	-	-	678	-	-	-	-	-	-	-	-
Shares Outstanding	0.6%	159	158	158	158	158	157	157	157	150	148	146	146	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85.00	87.00
Float	-	-	-	26,500	-	-	-	26,100	-	-	-	60,200	-	-	-	46,200	-	-	-	48,200	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	61.2%	224	139	105	10.00	147	-52.00	125	172	282	-272	253	282	406	153	240	281	443	267	143	198	300
Share Based Compensation	8.0%	94.00	87.00	106	93.00	100	83.00	91.00	92.00	98.00	509	80.00	67.00	78.00	61.00	16.00	39.00	49.00	46.00	48.00	51.00	47.00
Cashflow From Investing	-60.4%	-85.00	-53.00	-37.00	-56.00	-102	-250	-165	-74.00	-	-2,448	3.00	1,376	-34.00	-65.00	-320	-135	-104	-218	79.00	988	-348
Cashflow From Financing	96.2%	-27.00	-707	-3.00	-473	956	28.00	-5.00	21.00	-129	-394	-496	968	-331	-101	-143	-191	-115	-173	-549	-60.00	-154
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	281	125	142	188	63.00	198	-	63.00	98.00

ILMN Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Jan. 02, 2022
Revenue:
Total revenue	$ 4,504	$ 4,584	$ 4,526
Cost of revenue:
Amortization of acquired intangible assets	191	173	71
Total cost of revenue	1,760	1,612	1,372
Gross profit	2,744	2,972	3,154
Operating expense:
Research and development	1,354	1,321	1,185
Selling, general and administrative	1,612	1,297	2,092
Goodwill and intangible impairment	827	3,914	0
Legal contingency and settlement	20	619	0
Total operating expense	3,813	7,151	3,277
Loss from operations	(1,069)	(4,179)	(123)
Other income (expense):
Interest income	58	11	0
Interest expense	(77)	(26)	(61)
Other (expense) income, net	(29)	(142)	1,068
Total other (expense) income, net	(48)	(157)	1,007
(Loss) income before income taxes	(1,117)	(4,336)	884
Provision for income taxes	44	68	122
Net (loss) income	$ (1,161)	$ (4,404)	$ 762
(Loss) earnings per share:
Basic (in dollars per share)	$ (7.34)	$ (28.00)	$ 5.07
Diluted (in dollars per share)	$ (7.34)	$ (28.00)	$ 5.04
Shares used in computing (loss) earnings per share:
Basic (in shares)	158	157	150
Diluted (in shares)	158	157	151
Product revenue
Revenue:
Total revenue	$ 3,787	$ 3,953	$ 3,968
Cost of revenue:
Cost of revenue	1,177	1,144	1,060
Service and other revenue
Revenue:
Total revenue	717	631	558
Cost of revenue:
Cost of revenue	$ 392	$ 295	$ 241

ILMN Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2023	Jan. 01, 2023
Current assets:
Cash and cash equivalents	$ 1,048	$ 2,011
Short-term investments	6	26
Accounts receivable, net	734	671
Inventory, net	587	568
Prepaid expenses and other current assets	234	285
Total current assets	2,609	3,561
Property and equipment, net	1,007	1,091
Operating lease right-of-use assets	544	653
Goodwill	2,545	3,239
Intangible assets, net	2,993	3,285
Other assets	413	423
Total assets	10,111	12,252
Current liabilities:
Accounts payable	245	293
Accrued liabilities	1,325	1,232
Term notes, current portion	0	500
Convertible senior notes, current portion	0	748
Total current liabilities	1,570	2,773
Operating lease liabilities	687	744
Term notes	1,489	1,487
Other long-term liabilities	620	649
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at December 31, 2023 and January 1, 2023	0	0
Common stock, $0.01 par value, 320 million shares authorized; 199 million shares issued and 159 million outstanding at December 31, 2023; 198 million shares issued and 158 million outstanding at January 1, 2023	2	2
Additional paid-in capital	9,555	9,207
Accumulated other comprehensive (loss) income	(1)	3
(Accumulated deficit) retained earnings	(19)	1,142
Treasury stock, 40 million shares at both December 31, 2023 and January 1, 2023	(3,792)	(3,755)
Total stockholders’ equity	5,745	6,599
Total liabilities and stockholders’ equity	$ 10,111	$ 12,252

About Illumina Inc

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

CEO	Mr. Charles E. Dadswell Esq.
WEBSITE	illumina.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	11500

Illumina Inc Frequently Asked Questions

What is the ticker symbol for Illumina Inc? What does ILMN stand for in stocks?

ILMN is the stock ticker symbol of Illumina Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Illumina Inc (ILMN)?

As of Fri Apr 26 2024, market cap of Illumina Inc is 19.43 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers. The fair value of Illumina Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Illumina Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ILMN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Illumina Inc a good stock to buy?

The fair value guage provides a quick view whether ILMN is over valued or under valued. Whether Illumina Inc is cheap or expensive depends on the assumptions which impact Illumina Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ILMN.

What is Illumina Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, ILMN's PE ratio (Price to Earnings) is -16.74 and Price to Sales (PS) ratio is 4.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ILMN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Illumina Inc's stock?

In the past 10 years, Illumina Inc has provided -0.009 (multiply by 100 for percentage) rate of return.